Effect of aclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients

被引：7
|
作者：
Ciancio, G [1 ]
Burke, GW [1 ]
Suzart, K [1 ]
Mattiazzi, A [1 ]
Rosen, A [1 ]
Zilleruello, G [1 ]
Abitbol, C [1 ]
Montane, B [1 ]
Miller, J [1 ]
机构：
[1] Univ Miami, Sch Med, Dept Surg, Div Transplantat, Miami, FL 33136 USA
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(02)03131-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1944 / 1945
页数：2
相关论文
共 50 条
  • [41] Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients
    Labriffe, Marc
    Micallef, Ludovic
    Woillard, Jean-Baptiste
    Monchaud, Caroline
    Saint-Marcoux, Franck
    Debord, Jean
    Marquet, Pierre
    [J]. THERAPEUTIC DRUG MONITORING, 2023, 45 (05) : 591 - 598
  • [42] Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients
    Sobiak, Joanna
    Kaminska, Jolanta
    Glyda, Maciej
    Duda, Grazyna
    Chrzanowska, Maria
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (04) : E407 - E414
  • [43] Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients
    Ghio, L
    Ferraresso, M
    Viganó, SM
    Ginevri, F
    Perfumo, F
    Gianoglio, B
    Murer, L
    Zacchello, G
    Dello Strologo, L
    Cardillo, M
    Tirelli, S
    Valente, U
    Edefonti, A
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 856 - 858
  • [44] Mycophenolate mofetil dose adjustment in pediatric kidney transplant recipients
    Labriffe, Marc
    Micallef, Ludovic
    Woillard, Jean-Baptiste
    Monchaud, Caroline
    Saint-Marcoux, Franck
    Debord, Jean
    Marquet, M. Pierre
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 349 - 349
  • [45] Withdrawal of Mycophenolate Mofetil in stable renal transplant recipients.
    Meier-Kriesche, HU
    Kaza, H
    Thambuganipalle, R
    Vaghela, M
    Jacobs, HG
    Mulgaonkar, SP
    Friedman, GS
    Kaplan, B
    [J]. TRANSPLANTATION, 2000, 69 (08) : S132 - S132
  • [46] Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients
    Chueh, SC
    Huang, CY
    Lai, MK
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1901 - 1902
  • [47] Mycophenolate mofetil pharmacokinetics in renal transplant recipients on peritoneal dialysis
    Morgera, S
    Budde, K
    Lampe, D
    Ahnert, V
    Fritsche, L
    Kuchinke, S
    Neumayer, HH
    [J]. TRANSPLANT INTERNATIONAL, 1998, 11 (01) : 53 - 57
  • [48] A protocol for the safe discontinuation of mycophenolate mofetil in renal transplant recipients
    Khushu, S
    Shragg, P
    Savage, B
    Pierce, L
    Steiner, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 368A - 368A
  • [49] Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
    Falck, Pal
    Vethe, Nils Tore
    Asberg, Anders
    Midtvedt, Karsten
    Bergan, Stein
    Reubsaet, Jan Leo Egge
    Holdaas, Hallvard
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (03) : 1048 - 1053
  • [50] Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil
    François, M
    Büchler, M
    Halimi, JM
    Al-Najjar, A
    Valentin, JF
    Thibault, G
    Lebranchu, Y
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2781 - 2782
12345